pomalidomide,Isatuximab,dexamethasone
bms,sanofi
isatuximab with pomalidomide and dexamethasone resulted in meaningful effectiveness and demonstrated a manageable safety profile in adult patients with multiple myeloma who have received at least 2 prior therapies. #mmsm #ims2022 
Oncology news and insights from leading researchers and cancer centers.